Silexion Therapeutics, Tonix Pharmaceuticals, and Trinity Biotech Plc. are the 3 Penny Stocks to watch on January 30, 2025, based on TipRanks’ Penny Stock Screener tool. Penny stocks are defined as stocks that trade at or below $5 per share and have a market capitalization of below $300 million.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The Penny Stock Screener helps investors scan stocks based on numerous parameters, including Sector, Price Target Upside, Smart Score, Analyst Consensus, Dollar Volume, and Price Change.
We leveraged the tool to pick the top three penny stocks with the highest Dollar Volume as of the close on January 29, 2025. Simply put, Dollar Volume is the number of shares traded on a particular day multiplied by the day’s share price.
Silexion Therapeutics (SLXN) – Silexion Therapeutics is a clinical-stage oncology-focused biotechnology company that develops proprietary treatments for KRAS-driven cancers. On January 29, SLXN had a Dollar Volume of $323.94 million, while its stock price skyrocketed by 132.6%.
SLXN shares have been on an uptrend since January 28, when the company announced positive results from its pre-clinical pancreatic cancer models. The trials showed strong tumor growth reduction through systemic administration of its SIL-204 drug. Shares jumped in reaction to the news yesterday.
However, shares were trending down by more than 30% in Thursday’s pre-market trading as SLXN announced the exercise of warrants, raising gross proceeds of $3.3 million.
Tonix Pharmaceuticals Holdings Corp. (TNXP) – Tonix Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing treatments and vaccines for pain management and public health challenges.
TNXP had a Dollar Volume of $175.69 million yesterday, while its stock price fell by 6.5%. Shares continued the downtrend in pre-market trading this morning. While there was no specific news for Tonix yesterday, shares have been rather volatile in the past month and have gained over 19%. On January 8, Tonix announced that the U.S. Food and Drug Administration (FDA) assigned a Prescription Drug User Fee Act (PDUFA) goal date of August 15, 2025, for a decision on the marketing approval for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia.
Trinity Biotech PLC. (TRIB) – Trinity Biotech engages in the development and marketing of clinical diagnostic test kits, with a focus on human diagnostics and diabetic management solutions. TRIB had a Dollar Volume of $159.80 million on January 29, accompanied by a stock price fall of 2.9%.
TRIB shares have skyrocketed over 73% in the past two days on positive developments. On January 28, Trinity Biotech announced breakthrough results from the pre-pivotal trial of its Disruptive Continuous Glucose Monitoring (CGM) Technology. Shares jumped nearly 79% on the news on Tuesday.
To find more penny stocks like these, you can take a look at TipRanks’ Penny Stock Screener tool. It shows a list of all penny stocks, their price movement, and other vital data.
